Yood MU - Search Results

1

Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia.

Yood MU, Oliveria SA, Cziraky M, Hirji I, Hamdan M, Davis C. Yood MU, et al. Curr Med Res Opin. 2012 Feb;28(2):213-9. doi: 10.1185/03007995.2011.649849. Epub 2012 Jan 9. Curr Med Res Opin. 2012. PMID: 22168217

2

The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

Yood MU, DeLorenze G, Quesenberry CP Jr, Oliveria SA, Tsai AL, Willey VJ, McQuade R, Newcomer J, L'Italien G. Yood MU, et al. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):791-9. doi: 10.1002/pds.1781. Pharmacoepidemiol Drug Saf. 2009. PMID: 19526626

3

Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy.

Yood MU, Wells KE, Alford SH, Dakki H, Beiderbeck AB, Hurria A, Gross CP, Oliveria SA. Yood MU, et al. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):818-27. doi: 10.1002/pds.3239. Epub 2012 Mar 15. Pharmacoepidemiol Drug Saf. 2012. PMID: 22419528 Free PMC article.

4

Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy.

Yood MU, McCarthy BD, Kempf J, Kucera GP, Wells K, Oliveria S, Stang P. Yood MU, et al. Am Heart J. 2006 Oct;152(4):777-84. doi: 10.1016/j.ahj.2006.02.036. Am Heart J. 2006. PMID: 16996858

5

Patient characteristics and participation in a genetic study: a type 2 diabetes cohort.

Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Yood MU, Thomas A, Lanfear DE. Amiri L, et al. Among authors: yood mu. J Investig Med. 2014 Jan;62(1):26-32. doi: 10.2310/JIM.0000000000000022. J Investig Med. 2014. PMID: 24379022 Free PMC article.

6

Treatment and referral patterns for colorectal cancer.

Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Oliveria SA, et al. Among authors: yood sm, yood mu. Med Care. 2004 Sep;42(9):901-6. doi: 10.1097/01.mlr.0000135820.44720.89. Med Care. 2004. PMID: 15319616

7

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Arellano FM, et al. Among authors: yood mu. Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72. doi: 10.1002/pds.1343. Pharmacoepidemiol Drug Saf. 2006. PMID: 17086563

8

Time to pharmacotherapy change in response to elevated HbA1c test results.

Yood MU, Lafata JE, Koro C, Wells KE, Pladevall M. Yood MU, et al. Curr Med Res Opin. 2006 Aug;22(8):1567-74. doi: 10.1185/030079906X112750. Curr Med Res Opin. 2006. PMID: 16870081

9

Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.

Donato BM, Burns L, Willey V, Cohenuram M, Oliveria S, Yood MU. Donato BM, et al. Among authors: yood mu. Clin Ther. 2010 Mar;32(3):546-54. doi: 10.1016/j.clinthera.2010.03.007. Clin Ther. 2010. PMID: 20399992

10

Colon polyp recurrence in a managed care population.

Yood MU, Oliveria S, Boyer JG, Wells K, Stang P, Johnson CC. Yood MU, et al. Arch Intern Med. 2003 Feb 24;163(4):422-6. doi: 10.1001/archinte.163.4.422. Arch Intern Med. 2003. PMID: 12588200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters